LS Investment Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

LS Investment Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-57	Closed	-$5K	–	1896
2018 Q1	$5K	Hold	57	–	–	﹤0.01%	1771
2017 Q4	$5K	Hold	57	–	–	﹤0.01%	1788
2017 Q3	$5K	Hold	57	–	–	﹤0.01%	1779
2017 Q2	$4K	Hold	57	–	–	﹤0.01%	1787
2017 Q1	$4K	Hold	57	–	–	﹤0.01%	1785
2016 Q4	$3K	Hold	57	–	–	﹤0.01%	1790
2016 Q3	$4K	Hold	57	–	–	﹤0.01%	1762
2016 Q2	$3K	Hold	57	–	–	﹤0.01%	1783
2016 Q1	$3K	Hold	57	–	–	﹤0.01%	1765
2015 Q4	$4K	Hold	57	–	–	﹤0.01%	1770
2015 Q3	$4K	Hold	57	–	–	﹤0.01%	1754
2015 Q2	$5K	Hold	57	–	–	﹤0.01%	1742
2015 Q1	$4K	Hold	57	–	–	﹤0.01%	864
2014 Q4	$4K	Hold	57	–	–	﹤0.01%	879
2014 Q3	$3K	Buy	+57	New	+$2.91K	﹤0.01%	898

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

LS Investment Advisors's XBI Position: Q2 2018 in Review

LS Investment Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2018, closing a stake of 57 shares — an estimated $5K sold.

LS Investment Advisors first reported a position in XBI in Q3 2014 and held it in 15 quarters. The position peaked at $5K in Q1 2018. 430 funds tracked by Wall St. Rank hold XBI as of Q2 2018.

LS Investment Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2018 after selling out during the quarter.
LS Investment Advisors sold 57 State Street SPDR S&P Biotech ETF shares in Q2 2018, an estimated $5K.
LS Investment Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2014 and held it in 15 quarters.
LS Investment Advisors's State Street SPDR S&P Biotech ETF position peaked at $5K in Q1 2018.
430 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2018.

Based on LS Investment Advisors's 13F filing for Q2 2018, filed 20 Jul 2018.